Day: November 13
Blood-Based Diagnostic Strategies: Business and Clinical Approaches for the Future of Precision Oncology
Welcome Reception
Emerging Personalized Medicine Disciplines: Biomarker-driven treatment strategies in cardiovascular, neurodegenerative, and infectious diseases
Presentation of the 20th Annual Award for Leadership in Personalized Medicine
Artificial Intelligence Driven Platforms Driving Biomarker and Treatment Development
Machine Learning and Artificial intelligence technologies can drive biomarker discovery and validation and more readily explore divergent effects of preventive and treatment interventions across extensive data sets. What might this mean for the future of personalized medicine and what is being done to realize that future?
Networking Break
Personalized Medicine and the Pharmaceutical Industry: A Keynote Interview
The Future of Cancer if We Deliver on the Promise of Emerging Early Detection Technologies
By detecting molecular cancer signals in blood samples of seemingly healthy patients, a new generation of early cancer detection tests promises to put more patients on the path to personalized cancer treatment, sooner, when cancer may be more effectively treated. What might this mean for the future of cancer care? Leading voices discuss.
